Constantinescu, R;
Krýsl, D;
Andrén, K;
Asztély, F;
Bergquist, F;
Zetterberg, H;
Andreasson, U;
... Blennow, K; + view all
(2017)
Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.
Journal of Neuroimmunology
, 306
pp. 25-30.
10.1016/j.jneuroim.2017.02.018.
Preview |
Text
Constantinescu.pdf - Accepted Version Download (138kB) | Preview |
Abstract
Autoimmune neurologic syndromes can be paraneoplastic (associated with malignancies and/or onconeural antibodies), or non-paraneoplastic. Their clinical presentation is often similar. As prognosis is related to malignancy treatment, better biomarkers are needed to identify patients with malignancy. We investigated cerebrospinal fluid (CSF) markers of neuronal (neurofilament light chain, NFL and total tau protein, T-tau) and glial (glial fibrillary acidic protein) damage. CSF-NFL and T-tau were increased in both paraneoplastic and non-paraneoplastic autoimmune syndromes. Patients with manifest malignancies were older, had less epilepsy, more focal central and peripheral neurological signs and symptoms, and worse long-term outcome, than those without malignancy. CSF-NFL-levels predicted long-term outcome but were not diagnostic for malignancy, after age adjustment.
| Type: | Article |
|---|---|
| Title: | Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jneuroim.2017.02.018 |
| Publisher version: | http://dx.doi.org/10.1016/j.jneuroim.2017.02.018 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Autoimmune neurological syndrome; Paraneoplastic neurologic syndrome; Non-paraneoplastic; Autoimmune encephalitis; Neurofilament light chain; Tau protein |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1549746 |
Archive Staff Only
 |
View Item |
